70 related articles for article (PubMed ID: 26525938)
1. [Possibilities of the treatment of speech impairment in the acute stage of ischemic stroke using neuroprotective therapy].
Belskaya GN; Krilova LG; Sokolov MA; Izmailov IA
Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(9 Pt 2):60-63. PubMed ID: 26525938
[TBL] [Abstract][Full Text] [Related]
2. [The effect of cellex on cognitive and speech impairments in the acute stage of stroke].
Kovalenko AV; Safronova MN
Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(1):40-44. PubMed ID: 25909788
[TBL] [Abstract][Full Text] [Related]
3. [The experience of using cellex in treatment of patients with acute ischemic stroke].
Gaponenko IA; Bakhareva EV; Zolotareva ZM; Zuev GI; Rozhdestvenskiy AS
Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(4):43-47. PubMed ID: 29863691
[TBL] [Abstract][Full Text] [Related]
4. [Cellex in the treatment of patients with acute disturbance of cerebral blood circulation: results of a multicenter comparative open clinical trial].
Pizova NV; Sokolov MA; Izmaĭlov IA
Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(5):22-6. PubMed ID: 24988954
[TBL] [Abstract][Full Text] [Related]
5. The Membrane-Activated Chelator Stroke Intervention (MACSI) Trial of DP-b99 in acute ischemic stroke: a randomized, double-blind, placebo-controlled, multinational pivotal phase III study.
Rosenberg G; Bornstein N; Diener HC; Gorelick PB; Shuaib A; Lees K;
Int J Stroke; 2011 Aug; 6(4):362-7. PubMed ID: 21645269
[TBL] [Abstract][Full Text] [Related]
6. The role of piracetam in the treatment of acute and chronic aphasia.
Huber W
Pharmacopsychiatry; 1999 Mar; 32 Suppl 1():38-43. PubMed ID: 10338107
[TBL] [Abstract][Full Text] [Related]
7. DP-b99, a membrane-activated metal ion chelator, as neuroprotective therapy in ischemic stroke.
Diener HC; Schneider D; Lampl Y; Bornstein NM; Kozak A; Rosenberg G
Stroke; 2008 Jun; 39(6):1774-8. PubMed ID: 18403736
[TBL] [Abstract][Full Text] [Related]
8. Cerebrolysin and Recovery After Stroke (CARS): A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial.
Muresanu DF; Heiss WD; Hoemberg V; Bajenaru O; Popescu CD; Vester JC; Rahlfs VW; Doppler E; Meier D; Moessler H; Guekht A
Stroke; 2016 Jan; 47(1):151-9. PubMed ID: 26564102
[TBL] [Abstract][Full Text] [Related]
9. The effect of Ginkgo biloba on functional outcome of patients with acute ischemic stroke: a double-blind, placebo-controlled, randomized clinical trial.
Oskouei DS; Rikhtegar R; Hashemilar M; Sadeghi-Bazargani H; Sharifi-Bonab M; Sadeghi-Hokmabadi E; Zarrintan S; Sharifipour E
J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e557-63. PubMed ID: 23871729
[TBL] [Abstract][Full Text] [Related]
10. The effect of lithium in post-stroke motor recovery: a double-blind, placebo-controlled, randomized clinical trial.
Mohammadianinejad SE; Majdinasab N; Sajedi SA; Abdollahi F; Moqaddam MM; Sadr F
Clin Neuropharmacol; 2014; 37(3):73-8. PubMed ID: 24824661
[TBL] [Abstract][Full Text] [Related]
11. [Clinical and immunobiochemical study of efficacy and stress-protective properties of thyroliberin at the acute stage of carotid ischemic stroke].
Skvortsova VI; Platonova IA; Shamalov NA; Polepchuk AN; Maslak AA; Arsen'eva EL; Grivennikov IA
Zh Nevrol Psikhiatr Im S S Korsakova; 2006; Suppl 16():51-9. PubMed ID: 18196636
[TBL] [Abstract][Full Text] [Related]
12. Paracetamol (Acetaminophen) in stroke 2 (PAIS 2): protocol for a randomized, placebo-controlled, double-blind clinical trial to assess the effect of high-dose paracetamol on functional outcome in patients with acute stroke and a body temperature of 36.5 °C or above.
de Ridder IR; de Jong FJ; den Hertog HM; Lingsma HF; van Gemert HM; Schreuder AH; Ruitenberg A; Maasland EL; Saxena R; Oomes P; van Tuijl J; Koudstaal PJ; Kappelle LJ; Algra A; van der Worp HB; Dippel DW
Int J Stroke; 2015 Apr; 10(3):457-62. PubMed ID: 23692587
[TBL] [Abstract][Full Text] [Related]
13. NeuroThera® Efficacy and Safety Trial-3 (NEST-3): a double-blind, randomized, sham-controlled, parallel group, multicenter, pivotal study to assess the safety and efficacy of transcranial laser therapy with the NeuroThera® Laser System for the treatment of acute ischemic stroke within 24 h of stroke onset.
Zivin JA; Sehra R; Shoshoo A; Albers GW; Bornstein NM; Dahlof B; Kasner SE; Howard G; Shuaib A; Streeter J; Richieri SP; Hacke W;
Int J Stroke; 2014 Oct; 9(7):950-5. PubMed ID: 23013107
[TBL] [Abstract][Full Text] [Related]
14. Cerebrolysin in patients with acute ischemic stroke in Asia: results of a double-blind, placebo-controlled randomized trial.
Heiss WD; Brainin M; Bornstein NM; Tuomilehto J; Hong Z;
Stroke; 2012 Mar; 43(3):630-6. PubMed ID: 22282884
[TBL] [Abstract][Full Text] [Related]
15. [Characteristics of ischemic stroke according to hospital register data: a role of neuroreparative therapy].
Kulesh AA; Shestakov VV; Syromyatnikova LI; Kravtsova EY; Bokov KN; Dementyeva OV; Selezneva SI
Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(7):74-78. PubMed ID: 26356518
[TBL] [Abstract][Full Text] [Related]
16. A randomized placebo controlled trial of early treatment of acute ischemic stroke with atorvastatin and irbesartan.
Beer C; Blacker D; Bynevelt M; Hankey GJ; Puddey IB
Int J Stroke; 2012 Feb; 7(2):104-11. PubMed ID: 22044557
[TBL] [Abstract][Full Text] [Related]
17. Language features in the acute phase of poststroke severe aphasia could predict the outcome.
Glize B; Villain M; Richert L; Vellay M; de Gabory I; Mazaux JM; Dehail P; Sibon I; Laganaro M; Joseph PA
Eur J Phys Rehabil Med; 2017 Apr; 53(2):249-255. PubMed ID: 27412072
[TBL] [Abstract][Full Text] [Related]
18. [A randomized, double-blind, placebo-controlled study of Cerebrolysin safety and efficacy in the treatment of acute ischemic stroke].
Skvortsova VI; Stakhovskaia LV; Gubskiĭ LV; Shamalov NA; Tikhonova IV; Smychkov AS
Zh Nevrol Psikhiatr Im S S Korsakova; 2004; (Suppl 11):51-5. PubMed ID: 15559222
[TBL] [Abstract][Full Text] [Related]
19. Transcranial direct current stimulation in post-stroke sub-acute aphasia: study protocol for a randomized controlled trial.
Spielmann K; van de Sandt-Koenderman WM; Heijenbrok-Kal MH; Ribbers GM
Trials; 2016 Aug; 17():380. PubMed ID: 27484456
[TBL] [Abstract][Full Text] [Related]
20. Phosphodiesterase-5 Inhibitor PF-03049423 Effect on Stroke Recovery: A Double-Blind, Placebo-Controlled Randomized Clinical Trial.
Di Cesare F; Mancuso J; Woodward P; Bednar MM; Loudon PT;
J Stroke Cerebrovasc Dis; 2016 Mar; 25(3):642-9. PubMed ID: 26738812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
